Predictive Health Diagnostics Company Announces Expansion of North American Sales Force
Predictive Health Diagnostics Company expanding sales team to drive market expansion
PULS Cardiac Testâ„¢ and DIABETESpredictâ„¢ diagnostic tests now being marketed to healthcare providers throughout North America
Predictive Health Diagnostics Company Launches Second Diagnostic Test DIABETESpredictâ„¢ in North America
Enters into exclusive distribution agreement with Patia Europe SL, developer of DIABETESpredict.
Predictive Health Diagnostics Company Announces Strong Momentum with 120,000th PULS Cardiac Testâ„¢ Order
One-of-a-kind diagnostic blood test identifies asymptomatic at-risk patients missed by the current standard of care.
120,000th PULS Cardiac Testâ„¢ Order
One-of-a-kind diagnostic blood test identifies asymptomatic at-risk patients missed by the current standard of care
Predictive Health Diagnostics Company’s Proprietary Computational Technology Enables Development of Specialty Diagnostic Tests to Improve Patient Care
Company announces its business strategy including test development, commercialization, intellectual property, and reimbursement initiatives.
Computational Technology Enables Development
Data-driven technology platform innovates specialty diagnostic tests for diseases with the largest unmet medical needs